Tecan is collaborating with tissue engineering researchers at the University of Zurich to develop a novel, automated system for propagation of quality controlled cells that will
be suitable for use in regenerative medicine therapies, such as intervertebral disc implants. Tecan’s new solution will control all necessary cell culture steps, including the isolation,
seeding, proliferation, harvesting and analysis of cell lines and primary cells. Quality control will be maintained through two integrated detection devices that will determine the degree of cell confluence and detect the expression of cell type-specific
genetic markers. The platform will be easily adjusted for culture of multiple cell types, providing standardised and affordable treatment procedures for regenerative medicine.